Royce & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-9,000
Closed -$974K 1092
2016
Q1
$974K Hold
9,000
0.01% 930
2015
Q4
$924K Hold
9,000
0.01% 948
2015
Q3
$840K Buy
+9,000
New +$871K ﹤0.01% 986
2014
Q2
Sell
-7,300
Closed -$717K 1438
2014
Q1
$717K Sell
7,300
-4,000
-35% -$371K ﹤0.01% 1186
2013
Q4
$1.03M Sell
11,300
-2,200
-16% -$203K ﹤0.01% 1169
2013
Q3
$1.17M Sell
13,500
-26,700
-66% -$2.4M ﹤0.01% 1157
2013
Q2
$3.45M Buy
+40,200
New +$3.41M 0.01% 939

Other funds holding JNJ

Royce & Associates's JNJ Position: Q2 2016 in Review

Royce & Associates sold out of Johnson & Johnson (JNJ) in Q2 2016, closing a stake of 9,000 shares — an estimated $974K sold.

Royce & Associates first reported a position in JNJ in Q2 2013 and held it in 7 quarters. The position peaked at $3.45M in Q2 2013. 2,234 funds tracked by Wall St. Rank hold JNJ as of Q2 2016.

  • Royce & Associates reported no remaining Johnson & Johnson position as of Q2 2016 after selling out during the quarter.
  • Royce & Associates sold 9,000 Johnson & Johnson shares in Q2 2016, an estimated $974K.
  • Royce & Associates first reported a position in Johnson & Johnson in Q2 2013 and held it in 7 quarters.
  • Royce & Associates's Johnson & Johnson position peaked at $3.45M in Q2 2013.
  • 2,234 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2016.

Based on Royce & Associates's 13F filing for Q2 2016, filed 8 Aug 2016.